Latest News

Heliocare Launched in Rexall PharmaPlus Nationwide!
BASIS Medical Technologies and NETWORK Globalhealth announce new partnership agreement.
"Strataderm Scar Therapy in the News"


Basis To Attend 2014 CSAPS! More Info To Come, Stay Tuned!
The 75th Annual American Academy of Dermatology


Our extensive capabilities in research and development are an important part of Basis’ commitment to innovation. From concept and market assessment to clinical testing, FDA financing, commercialization and more, Basis facilitates R&D at all stages of a product’s development.

Our management team is proven and experienced with an established track record in North American and international regulatory and physician markets. In addition to building in-roads into high-value markets, Basis strives to develop brand credibility and awareness through clinical research with prominent advisory and scientific boards. Prior to adding new technologies to our platform, Basis seeks the approval of our world-class Medical Advisory Panel and proceeds only following their evaluation and with their endorsement.

For more information on our past, on-going or upcoming R&D efforts, please contact us directly.